/AMWL
AMWL Stock - American Well Corporation
Healthcare|Medical - Healthcare Information ServicesNYSE
$4.98+0.36%
+$0.02 (+0.36%) • Jan 13
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).91
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.69
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+20.5%upside
Target: $6.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AMWL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4.93 – $5.03
TARGET (TP)$6.00
STOP LOSS$4.58
RISK/REWARD1:2.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.27
52W High$12.95
52W Low$3.71
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $254.36M | $259.05M | $277.19M | $252.79M | $245.26M |
| Gross Profit | $65.98M | $63.27M | $90.61M | $88.23M | $78.32M |
| Gross Margin | 25.9% | 24.4% | 32.7% | 34.9% | 31.9% |
| Operating Income | $-196,642,000 | $-251,250,000 | $-258,125,000 | $-180,662,000 | $-220,955,000 |
| Net Income | $-208,143,000 | $-675,164,000 | $-270,429,000 | $-176,334,000 | $-224,432,000 |
| Net Margin | -81.8% | -260.6% | -97.6% | -69.8% | -91.5% |
| EPS | $-13.88 | $-47.50 | $-19.68 | $-13.88 | $-45.32 |
Company Overview
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
40%
Hold / Neutral
3
60%
Sell / Underperform
0%
Analyst Consensus🔴 Bearish
2 Bullish3 Neutral/Bearish
Price Targets
$6
Average Target
↑ 11.1% Upside
Now
$3
Low
$6
Average
$15
High
Based on 7 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| January 13th 2025 | Wells Fargo | Upgrade | Overweight | $15 |
| August 3rd 2023 | Morgan Stanley | Downgrade | Equal Weight | $2.5← $5 |
| March 23rd 2023 | TD Cowen | Downgrade | Market Perform | $2.5← $5 |
| February 27th 2023 | Piper Sandler | Downgrade | Neutral | $3.5← $5 |
| January 4th 2023 | BofA Securities | Upgrade | Buy | $4.2 |
| September 7th 2022 | Truist | Initiation | Hold | $5 |
| April 14th 2022 | Guggenheim | Initiation | Buy | $6 |
Earnings History & Surprises
AMWLBeat Rate
61%
Last 18 quarters
Avg Surprise
+5.8%
EPS vs Estimate
Beats / Misses
11/5
2 met exactly
Latest EPS
$-1.74
Q4 2025
EPS Surprise History
Q1 24
+10.5%
$-3.40vs$-3.80
Q2 24
-38.9%
$-5.00vs$-3.60
Q3 24
+14.7%
$-3.36vs$-3.94
Q4 24
+13.6%
$-2.87vs$-3.32
Q1 25
+8.9%
$-2.77vs$-3.04
Q2 25
+44.0%
$-1.73vs$-3.09
Q3 25
+32.6%
$-1.24vs$-1.84
Q4 25
-19.4%
$-1.74vs$-1.46
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 11, 2026 | $-1.59 | — | — | — |
Q4 2025 | Nov 4, 2025 | $-1.46 | $-1.74 | -19.4% | ✗ MISS |
Q3 2025 | Aug 5, 2025 | $-1.84 | $-1.24 | +32.6% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $-3.09 | $-1.73 | +44.0% | ✓ BEAT |
Q1 2025 | Feb 12, 2025 | $-3.04 | $-2.77 | +8.9% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $-3.32 | $-2.87 | +13.6% | ✓ BEAT |
Q3 2024 | Jul 31, 2024 | $-3.94 | $-3.36 | +14.7% | ✓ BEAT |
Q2 2024 | May 1, 2024 | $-3.60 | $-5.00 | -38.9% | ✗ MISS |
Q1 2024 | Feb 14, 2024 | $-3.80 | $-3.40 | +10.5% | ✓ BEAT |
Q4 2023 | Nov 1, 2023 | $-4.00 | $-4.00 | 0.0% | = MET |
Q3 2023 | Aug 2, 2023 | $-4.20 | $-4.60 | -9.5% | ✗ MISS |
Q2 2023 | May 3, 2023 | $-4.00 | $-4.80 | -20.0% | ✗ MISS |
Q1 2023 | Feb 22, 2023 | $-5.00 | $-4.40 | +12.0% | ✓ BEAT |
Q4 2022 | Nov 7, 2022 | $-5.20 | $-5.00 | +3.8% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $-5.00 | $-5.00 | 0.0% | = MET |
Q2 2022 | May 9, 2022 | $-4.40 | $-5.20 | -18.2% | ✗ MISS |
Q1 2022 | Feb 24, 2022 | $-5.60 | $-3.60 | +35.7% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $-4.60 | $-4.00 | +13.0% | ✓ BEAT |
Q3 2021 | Aug 11, 2021 | $-3.80 | $-3.00 | +21.1% | ✓ BEAT |
Latest News
Morgan Stanley Maintains Equal-Weight on American Well, Lowers Price Target to $6
➖ NeutralBenzinga•Dec 18, 2025, 05:41 PM
Wells Fargo Maintains Overweight on American Well, Lowers Price Target to $9
➖ NeutralBenzinga•Nov 5, 2025, 03:25 PM
American Well Narrows FY2025 Sales Guidance from $245.000M-$250.000M to $245.000M-$248.000M vs $247.785M Est
📉 NegativeBenzinga•Nov 4, 2025, 09:19 PM
American Well Sees Q4 Sales $51.000M-$54.000M vs $55.523M Est
📉 NegativeBenzinga•Nov 4, 2025, 09:18 PM
American Well Q3 EPS $(2.00) Misses $(1.72) Estimate, Sales $56.286M Beat $54.558M Estimate
➖ NeutralBenzinga•Nov 4, 2025, 09:18 PM
American Well Q1 beats propel 14% post-market stock surge
📈 PositiveSeeking Alpha•May 1, 2025, 10:04 PM
Frequently Asked Questions about AMWL
What is AMWL's current stock price?
American Well Corporation (AMWL) is currently trading at $4.98 per share. The stock has moved +0.36% today.
What is the analyst price target for AMWL?
The average analyst price target for AMWL is $6.00, based on 1 analyst.
What sector is American Well Corporation in?
American Well Corporation operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NYSE exchange.
What is AMWL's market cap?
American Well Corporation has a market capitalization of $0.08 billion, making it a small-cap company.
Does AMWL pay dividends?
No, American Well Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADVM
Adverum Biotechnologies, Inc.
$4.36
Mkt Cap: $0.1B
ALXO
ALX Oncology Holdings Inc.
$1.49
Mkt Cap: $0.1B
ATYR
aTyr Pharma, Inc.
$0.67
Mkt Cap: $0.1B
BMEA
Biomea Fusion, Inc.
$1.45
Mkt Cap: $0.1B
CAMP
CAMP4 Therapeutics Corporation
$6.00
Mkt Cap: $0.1B
DTIL
Precision BioSciences, Inc.
$3.93
Mkt Cap: $0.1B
EUDA
EUDA Health Holdings Limited
$2.67
Mkt Cap: $0.1B
GUTS
Fractyl Health, Inc. Common Stock
$2.02
Mkt Cap: $0.1B
IMUX
Immunic, Inc.
$0.66
Mkt Cap: $0.1B
RPTX
Repare Therapeutics Inc.
$2.56
Mkt Cap: $0.1B
Explore stocks similar to AMWL for comparison